Do stereotactic breast biopsy cuts promote lower-quality care?

01/13/2014 | (free registration)

Medicare's proposed reductions in stereotactic breast biopsy reimbursement will lead to more open surgical biopsies for women with suspicious breast masses, according to some experts. Image-guided biopsies are less invasive and more efficient, causing less morbidity while providing accurate diagnosis. Without payer support, however, clinicians will revert to the older technique. "With these cuts, it's like CMS is driving the wrong side of the horse," said radiologist Dr. Michael Linver. "Decreasing reimbursement for vacuum-assisted biopsies and moving back toward excisional biopsy is the opposite of what we want to do. It's a tremendous disincentive to do the right thing, medically."

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN